Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors

International Journal of Oncology

Volumn 44, Issue 5, 2014, Pages 1425-1432

  Panagopoulos, Ioannis ^a,b   Brandal, Petter ^a   Gorunova, Ludmila ^a,b   Bjerkehagen, Bodil ^a   Heim, Sverre ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

3 untranslated region; CSF1; CSF1 S100A10 fusion gene; RNA sequencing; Tenosynovial giant cell tumor

Indexed keywords

3' UNTRANSLATED REGION; ARTICLE; CASE REPORT; CONTROLLED STUDY; CSF1 GENE; EXON; FEMALE; FUSION GENE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GIANT CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; RNA SEQUENCE; S100A10 GENE; STOP CODON; SYNOVIUM; TENDON SHEATH; TENOSYNOVIAL GIANT CELL TUMOR;

3' UNTRANSLATED REGIONS; ANNEXIN A2; BASE SEQUENCE; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 1; EXONS; FEMALE; GIANT CELL TUMORS; HELA CELLS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; S100 PROTEINS; SEQUENCE ANALYSIS, RNA; SYNOVIAL MEMBRANE; TRANSLOCATION, GENETIC;

EID: 84899087455     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2326     Document Type: Article

References (36)

1. Jaffe HL, Lichtestein L and Sutro CJ: Pigmented villonodular synovitis, bursitis and tenosynovitis. A discussion of the synovial and bursal equivalents of the tenosynovial lesion commonly denoted as xanthoma, xanthogranuloma, giant cell tumor or myeloplaxoma of the tendon sheath, with some consideration of this tendon sheath lesion itself. Arch Pathol 31: 731-764, 1941.
2. Somerhausen NS and Fletcher CD: Diffuse-type giant cell tumor: clinicopathologic and immunohistochemical analysis of 50 cases with extraarticular disease. Am J Surg Pathol 24: 479-492, 2000.
3. Weiss SW and Goldblum JR: Enzinger and Weiss's Soft Tissue Tumors. Mosby, St. Louis, MO, 2001.
4. Myers BW and Masi AT: Pigmented villonodular synovitis and tenosynovitis: a clinical epidemiologic study of 166 cases and literature review. Medicine 59: 223-238, 1980. (Pubitemid 10117857)
5. Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F: WHO Classification of Tumours of Soft Tissue and Bone, Fourth edition. 2013.
6. Chassaignac CME: Cancer de la gaine des tendons. Gaz Hosp Civ Milit 47: 185-186, 1852.
7. Singh R, Grewal DS and Chakravarti RN: Experimental production of pigmented villonodular synovitis in the knee and ankle joints of rhesus monkeys. J Pathol 98: 137-142, 1969.
8. Sakkers RJ, de Jong D and van der Heul RO: X-chromosome inactivation in patients who have pigmented villonodular synovitis. J Bone Joint Surg Am 73: 1532-1536, 1991.
9. Vogrincic GS, O'Connell JX and Gilks CB: Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol 28: 815-819, 1997. (Pubitemid 27298967)
10. Choong PF, Willen H, Nilbert M, et al: Pigmented villonodular synovitis. Monoclonality and metastasis - a case for neoplastic origin? Acta Orthop Scand 66: 64-68, 1995.
11. Brandal P, Bjerkehagen B and Heim S: Molecular cytogenetic characterization of tenosynovial giant cell tumors. Neoplasia 6: 578-583, 2004. (Pubitemid 39411095)
12. Fletcher JA, Henkle C, Atkins L, Rosenberg AE and Morton CC: Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells. Genes Chromosomes Cancer 4: 264-266, 1992.
13. Mertens F, Orndal C, Mandahl N, et al: Chromosome aberrations in tenosynovial giant cell tumors and nontumorous synovial tissue. Genes Chromosomes Cancer 6: 212-217, 1993. (Pubitemid 23111755)
14. Nilsson M, Hoglund M, Panagopoulos I, et al : Molecular cytogenetic mapping of recurrent chromosomal breakpoints in tenosynovial giant cell tumors. Virchows Arch 441: 475-480, 2002. (Pubitemid 35430463)
15. Sciot R, Rosai J, Dal Cin P, et al: Analysis of 35 cases of localized and diffuse tenosynovial giant cell tumor: a report from the Chromosomes and Morphology (CHAMP) study group. Mod Pathol 12: 576-579, 1999. (Pubitemid 29279709)
16. Bertoni F, Unni KK, Beabout JW and Sim FH: Malignant giant cell tumor of the tendon sheaths and joints (malignant pigmented villonodular synovitis). Am J Surg Pathol 21: 153-163, 1997. (Pubitemid 27084054)
17. Layfield LJ, Meloni-Ehrig A, Liu K, Shepard R and Harrelson JM: Malignant giant cell tumor of synovium (malignant pigmented villonodular synovitis). Arch Pathol Lab Med 124: 1636-1641, 2000.
18. Ushijima M, Hashimoto H, Tsuneyoshi M, Enjoji M, Miyamoto Y and Okue A: Malignant giant cell tumor of tendon sheath. Report of a case. Acta Pathol Jpn 35: 699-709, 1985. (Pubitemid 15061397)
19. Mitelman F, Mertens F and Johansson B: Prevalence estimates of recurrent balanced cytogenetic aberrations and gene fusions in unselected patients with neoplastic disorders. Genes Chromosomes Cancer 43: 350-366, 2005. (Pubitemid 40946470)
20. West RB, Rubin BP, Miller MA, et al: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA 103: 690-695, 2006. (Pubitemid 43153087)
21. Möller E, Mandahl N, Mertens F and Panagopoulos I: Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors. Genes Chromosomes Cancer 47: 21-25, 2008. (Pubitemid 350191460)
22. Kawasaki ES and Ladner MB: Molecular biology of macrophage colony.stimulating factor. In: Colony Stimulating Factors: Molecular and Cellular Biology. Dexter TM, Garland JM and Testa NG (eds). Marcel Dekker, New York, NY, pp155-176, 1990.
23. Cupp JS, Miller MA, Montgomery KD, et al: Translocation and expression of CSF1 in pigmented villonodular synovitis, tenosynovial giant cell tumor, rheumatoid arthritis and other reactive synovitides. Am J Surg Pathol 31: 970-976, 2007. (Pubitemid 47165154)
24. Ge H, Liu K, Juan T, Fang F, Newman M and Hoeck W: Fusion Map: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics 27: 1922-1928, 2011.
25. Cleynen I and Van de Ven WJ: The HMGA proteins: a myriad of functions (Review). Int J Oncol 32: 289-305, 2008.
26. Asmann YW, Hossain A, Necela BM, et al: A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines. Nucleic Acids Res 39: e100, 2011.
27. Madureira PA, O'Connell PA, Surette AP, Miller VA and Waisman DM: The biochemistry and regulation of S100A10: a multifunctional plasminogen receptor involved in oncogenesis. J Biomed Biotechnol 2012: 353687, 2012.
28. Bonafé N, Gilmore-Hebert M, Folk NL, Azodi M, Zhou Y and Chambers SK: Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3′ untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. Cancer Res 65: 3762-3771, 2005. (Pubitemid 40616354)
29. Woo HH, Baker T, Laszlo C and Chambers SK: Nucleolin mediates microRNA-directed CSF-1 mRNA deadenylation but increases translation of CSF-1 mRNA. Mol Cell Proteomics 12: 1661-1677, 2013.
30. Woo HH, Laszlo CF, Greco S and Chambers SK: Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152. Mol Cancer 11: 58, 2012.
31. Zhou Y, Yi X, Stoffer JB, et al: The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer. Mol Cancer Res 6: 1375-1384, 2008.
32. Bakheet T, Frevel M, Williams BR, Greer W and Khabar KS: ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29: 246-254, 2001. (Pubitemid 32054460)
33. Dewar AL, Cambareri AC, Zannettino AC, et al: Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. Blood 105: 3127-3132, 2005.
34. Blay JY, El Sayadi H, Thiesse P, Garret J and Ray-Coquard I: Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT). Ann Oncol 19: 821-822, 2008. (Pubitemid 351461057)
35. Cassier PA, Gelderblom H, Stacchiotti S, et al: Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis. Cancer 118: 1649-1655, 2012.
36. Stacchiotti S, Crippa F, Messina A, et al: Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib. Clin Sarcoma Res 3: 8, 2013.